TEVJF (Teva Pharmaceutical Industries) Beginning Cash Position : $3,318 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Teva Pharmaceutical Industries Beginning Cash Position?

Teva Pharmaceutical Industries's Beginning Cash Position for the quarter that ended in Dec. 2024 was $3,318 Mil.

Teva Pharmaceutical Industries's quarterly Beginning Cash Position declined from Jun. 2024 ($2,992 Mil) to Sep. 2024 ($2,258 Mil) but then increased from Sep. 2024 ($2,258 Mil) to Dec. 2024 ($3,318 Mil).

Teva Pharmaceutical Industries's annual Beginning Cash Position increased from Dec. 2022 ($2,198 Mil) to Dec. 2023 ($2,834 Mil) and increased from Dec. 2023 ($2,834 Mil) to Dec. 2024 ($3,226 Mil).

Teva Pharmaceutical Industries Beginning Cash Position Historical Data

The historical data trend for Teva Pharmaceutical Industries's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Beginning Cash Position Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

1,975.00

2,177.00

2,198.00

2,834.00

3,226.00

Teva Pharmaceutical Industries Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															2,250.00	3,226.00	2,992.00	2,258.00	3,318.00

Teva Pharmaceutical Industries Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Teva Pharmaceutical Industries Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (OTCPK:TEVJF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TEVA:USA TEVA N:Mexico TEVA:Israel 0LER:UK TEV:Germany T1EV34:Brazil TEV:Bulgaria TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.